Preoperative neoadjuvant androgen withdrawal therapy in prostate cancer: The Canadian experience - Discussion

被引：0
|
作者：
Kantoff, PW [1 ]
Klotz, L
D'Amico, AV
Smith, MR
Carroll, PR
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Univ Toronto, Toronto, ON, Canada
[3] Brigham & Womens Hosp, Boston, MA 02115 USA
[4] Massachusetts Gen Hosp, Boston, MA 02114 USA
[5] Univ Calif San Francisco, San Francisco, CA 94143 USA
来源：
UROLOGY | 2002年 / 60卷 / 3A期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：51 / 51
页数：1
相关论文
共 50 条
  • [31] The efficacy of neoadjuvant androgen deprivation therapy as a prostate volume reduction before brachytherapy for clinically localized prostate cancer
    Ebara, Shin
    Manabe, Daisuke
    Kobayashi, Yasuyuki
    Tanimoto, Ryuta
    Saika, Takashi
    Nasu, Yasutomo
    Saito, Shirou
    Satoh, Takefumi
    Miki, Kenta
    Hashine, Katsuyoshi
    Kumon, Hiromi
    ACTA MEDICA OKAYAMA, 2007, 61 (06) : 335 - 340
  • [32] Androgen and prostate cancer: the role of primary androgen deprivation therapy in localized prostate cancer
    Namiki, Mikio
    Kitagawa, Yasuhide
    Mizokami, Atsushi
    Koh, Eitetsu
    JOURNAL OF MENS HEALTH, 2008, 5 (04) : 333 - 341
  • [33] Reversible Parkinson's Dementia Associated with Withdrawal of Androgen-Deprivation Therapy for Prostate Cancer
    Abbate, Carlo
    Caputo, Ludovica
    Damanti, Sarah
    Zappa, Carlo
    Nicolini, Paola
    Rossi, Paolo D.
    Arosio, Beatrice
    Mari, Daniela
    De Riz, Milena A.
    Dormia, Guido
    Trimarchi, Pietro D.
    Morello, Elisabetta
    Monfardini, Silvio
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2016, 64 (10) : E115 - E117
  • [34] Hormone-refractory prostate cancer? Anti-androgen withdrawal and intermittent hormone therapy
    Sciarra, A
    Casale, P
    Colella, D
    Di Chiro, C
    Di Silverio, F
    SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 1999, 33 (04): : 211 - 216
  • [35] Biochemical and pathological effects of 8 months of neoadjuvant androgen withdrawal therapy before radical prostatectomy in patients with clinically confined prostate cancer - Editorial comment
    Garnick, MB
    JOURNAL OF UROLOGY, 1996, 155 (01): : 212 - 212
  • [36] Androgen deprivation therapy for prostate cancer
    Das, Manjulika
    LANCET ONCOLOGY, 2017, 18 (10): : E567 - E567
  • [37] Androgen receptor as a target in androgen-independent prostate cancer - Discussion
    Sartor, O
    Balk, SP
    Brown, M
    UROLOGY, 2002, 60 (3A) : 138 - 139
  • [38] Contemporary patterns of androgen deprivation therapy use for newly diagnosed prostate cancer - Discussion
    Sartor, O
    Carroll, PR
    Pollack, A
    D'Amico, AV
    Kantoff, PW
    UROLOGY, 2002, 60 (3A) : 11 - 12
  • [39] Androgen Deprivation Therapy for Prostate Cancer
    Pagliarulo, Vincenzo
    MOLECULAR & DIAGNOSTIC IMAGING IN PROSTATE CANCER: CLINICAL APPLICATIONS AND TREATMENT STRATEGIES, 2019, 1126 : 1 - 30
  • [40] Impact of androgen deprivation therapy on survival in men treated with radiation for prostate cancer - Discussion
    Lee, WR
    Pollak, A
    Carroll, PR
    Klotz, L
    D'Amico, AV
    Kelly, WK
    Sartor, O
    Kantoff, PW
    UROLOGY, 2002, 60 (3A) : 30 - 31
12345